Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Maze Therapeutics (MAZE) EBT Margin (2024)

Maze Therapeutics has reported EBT Margin over the past 1 years, most recently at 1001.24% for Q3 2024.

  • Quarterly EBT Margin changed N/A to 1001.24% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 4854.0% through Jun 2025, changed N/A year-over-year, with the annual reading at 31.88% for FY2024, N/A changed from the prior year.
  • EBT Margin was 1001.24% for Q3 2024 at Maze Therapeutics, down from 938.55% in the prior quarter.
  • Over five years, EBT Margin peaked at 938.55% in Q2 2024 and troughed at 1001.24% in Q3 2024.